Government Briefs

Yale physicist D. Allan Bromley, already a member of the low-profile White House Science Council, will soon be wearing a second, more visible Washington science policy hat. On July 25, President Reagan announced Bromley’s nomination to the National Science Board, which oversees NSF. Staffers at each body say they foresee no conflicts between the two positions, adding that Bromley’s most serious problem may be finding sufficient time to serve on each panel. Bromley is part of Vice

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Yale physicist D. Allan Bromley, already a member of the low-profile White House Science Council, will soon be wearing a second, more visible Washington science policy hat. On July 25, President Reagan announced Bromley’s nomination to the National Science Board, which oversees NSF. Staffers at each body say they foresee no conflicts between the two positions, adding that Bromley’s most serious problem may be finding sufficient time to serve on each panel. Bromley is part of Vice President Bush’s network of science advisers and a likely candidate for a job in a Bush administration (The Scientist, June 27, page 1). As a result, Reagan’s announcement has triggered speculation that Bromley is being appointed to the 24-member science board to keep him active in the science policy community even in the event of a Dukakis victory this fall.

Meanwhile, the science council is making its own news by scheduling a rare ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies